OakChart

Veradermics Inc

MANEHealthcare·Biotechnology·USA·Mid·NYSE·Nov 11 • 3:59 PM ET

156.56+8.12 (5.47%)
2026-11-12 03:35 CET
Market cap
6,541.09 USD m
Revenue, TTM
0.00 USD m
Net income, TTM
-21.00 USD m
Free cash flow, TTM
-23.29 USD m
EPS diluted, TTM
-0.50
P/E
-
Compare

Price

MANE against its 20 and 50-day averages
2050beatmiss
80.00100.00120.00140.00160.002.0M4.0MVolumeMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26MANEclose 156.5620-day 135.4350-day 120.86156.56

At the 52-week high of 156.63 on 11 Nov 2026. 52-week low 32.00 on 4 Feb 2026. Last 15 sessions, 25.0% high to low

Volume 0.98× normal · the line is the 50-bar volume average

Profile

MANE
52-week range, 100% of the way up
32.00152.82

Veradermics, Inc. is a late clinical-stage biopharmaceutical company. It focuses on developing innovative therapeutics to address pervasive treatment challenges in highly prevalent aesthetic and dermatological conditions. The company was founded in 2019 and is headquartered in New Haven, CT.

IndexRUT
Employees21
IPOFeb 04, 2026
ATR, 14d9.15
Rel volume0.98
Short float11.35%
Insider own28.54%
Inst own70.00%

Snapshot

6 groups

Valuation

IndexRUT
Market Cap6.54B
Enterprise Value5.74B
Income-102.72M
Sales-
Book/sh18.88
Cash/sh19.11
Dividend Est.-
Dividend TTM-
Dividend Ex-Date-
Dividend Gr. 3/5Y- -
Payout-
Employees21
IPOFeb 04, 2026

Ratios

P/E-
Forward P/E-
PEG-
P/S-
P/B8.29
P/C8.19
P/FCF-
EV/EBITDA-
EV/Sales-
Quick Ratio77.68
Current Ratio77.68
Debt/Eq0.00
LT Debt/Eq0.00
Option/ShortYes / Yes

Earnings

EPS (ttm)-2.62
EPS next Y-2.52
EPS next Q-0.60
EPS this Y18.74%
EPS next Y8.40%
EPS next 5Y26.04%
EPS past 3/5Y-117.94% -
Sales past 3/5Y- -
EPS Y/Y TTM-
Sales Y/Y TTM-
EPS Q/Q17.64%
Sales Q/Q-
EarningsNov 10 BMO
EPS/Sales Surpr.-1.26% -

Ownership

Insider Own28.54%
Insider Trans-7.46%
Inst Own70.00%
Inst Trans20.02%
ROA-65.46%
ROE-70.00%
ROIC-
Gross Margin-
Oper. Margin-
Profit Margin-
SMA2015.60%
SMA5029.54%
SMA20063.57%
Trades-

Technical

Shs Outstand42.19M
Shs Float29.86M
Short Float11.35%
Short Ratio4.64
Short Interest3.39M
52W High152.82 2.45%
52W Low32.00 389.25%
Volatility8.35% 6.83%
ATR (14)9.15
RSI (14)67.64
Beta-
Rel Volume0.98
Avg Volume730.46K
Volume713,872

Performance

Perf Week14.69%
Perf Month34.66%
Perf Quarter41.05%
Perf Half Y46.13%
Perf YTD360.47%
Perf Year-
Perf 3Y-
Perf 5Y-
Perf 10Y-
Recom1.00
Target Price178.17
Prev Close148.44
Price156.56
Change %5.47%

Analyst ratings

latest 6 of 6
DateActionAnalystRating changeTargetImplied
Jul 15, 2026InitiatedRB. Riley SecuritiesBuy$170+8.6%
Jun 02, 2026InitiatedNNeedhamBuy$136-13.1%
Mar 02, 2026InitiatedLLeerink PartnersOutperform$75-52.1%
Mar 02, 2026InitiatedJJefferiesBuy$75-52.1%
Mar 02, 2026InitiatedCCitigroupBuy$85-45.7%
Mar 02, 2026InitiatedCCantor FitzgeraldOverweight

Peers

Mkt cap
TickerCompanyMkt cap
ARQTArcutis Biotherapeutics Inc3.59B
HIMSHims & Hers Health Inc4.86B
ORKAOruka Therapeutics Inc7.27B
INCYIncyte Corp24.92B
KVUEKenvue Inc37.09B
ACRSAclaris Therapeutics Inc688.38M
BHCBausch Health Companies Inc3.13B
EOLSEvolus Inc491.11M
LLYLilly(Eli) & Co1352.12B
PFEPfizer Inc167.86B

Insider trading

latest 14 of 19
InsiderRelationshipDateTransactionCostSharesValueTotal heldForm
MONTANOVA CAPITAL, LLCDirectorAug 19 '26Sale107.25750,00080,437,500461,033Aug 21 06:11 PM
Averill Master Fund, Ltd.AffiliateAug 19 '26Proposed Sale107.25690,60174,066,957Aug 19 07:14 PM
Averill Madison Master Fund, LAffiliateAug 19 '26Proposed Sale107.2559,3996,370,543Aug 19 07:12 PM
Durso Timothy AugustChief Technical OfficerAug 17 '26Option Exercise12.193,45242,080121,642Aug 18 09:10 PM
Durso Timothy AugustChief Technical OfficerAug 17 '26Sale107.8243,5004,690,00578,142Aug 18 09:10 PM
Waldman Reid AlexanderChief Executive OfficerAug 17 '26Option Exercise12.193,45242,080238,324Aug 18 09:04 PM
Waldman Reid AlexanderChief Executive OfficerAug 17 '26Sale107.8667,5007,280,713170,824Aug 18 09:04 PM
Timothy DursoOfficerAug 17 '26Proposed Sale111.2887,0009,681,360Aug 17 05:39 PM
Reid Alexander WaldmanCEOAug 17 '26Proposed Sale111.28135,00015,022,800Aug 17 05:30 PM
CHILDS JOHN WDirectorAug 12 '26Sale107.12100,00010,711,700194,117Aug 14 06:01 PM
AMZL, LPShareholderAug 12 '26Proposed Sale108.95104,58711,394,754Aug 12 06:01 PM
SR One Capital Fund II AggregaShareholderAug 12 '26Proposed Sale108.95217,16223,659,800Aug 12 06:00 PM
SUVRETTA CAPITAL MANAGEMENT, LDirectorFeb 04 '26Buy37.05155,9535,778,3423,648,538Feb 09 06:28 PM
SUVRETTA CAPITAL MANAGEMENT, LDirectorFeb 05 '26Buy37.9996,2003,655,079489,932Feb 09 06:28 PM

Held by

AUM
TickerCompanyAUM
VTIVanguard Morningstar Total Stock Market ETFAUM: 687.42B
IWMiShares Russell 2000 Index FundAUM: 77.38B
VXFVanguard Extended Market Index ETFAUM: 30.47B
SCHASchwab U.S. Small-Cap ETFAUM: 22.25B
JGROJPMorgan Active Growth ETFAUM: 9.31B
IWOiShares Russell 2000 Growth ETFAUM: 14.06B
IHEiShares U.S. Pharmaceuticals ETFAUM: 1.72B
VTWOVanguard Russell 2000 Index ETFAUM: 16.75B
XPHState Street SPDR S&P Pharmaceuticals ETFAUM: 516.35M
IWNiShares Russell 2000 Value ETFAUM: 14.10B

News

latest 14 of 96

Quarterly earnings

actual against estimate
PeriodReportedEPS actEPS estEPS repSales actSales estAnalysts
2026Q32026-11-10-0.610-0.602-0.4980.000.006
2026Q22026-08-11-0.574-0.648-0.5630.000.006
2026Q12026-05-12-1.184-0.637-0.8040.000.004
2025Q42026-03-30-1.061-1.812-0.7550.000.001
2026Q4---0.600--0.006
2027Q1---0.530--0.001
2027Q2---0.600--0.001
2027Q3---0.660--0.001
2027Q4---0.890--0.001

Annual earnings

PeriodEPS actEPS estEPS repSales actSales est
2025FY-3.392-6.752-0.000.00
2026FY--2.756--0.00
2027FY--2.525--12.47
2028FY--1.372--134.33
2029FY--0.278--230.28
2030FY-4.833--552.1

Estimate revisions

last 14 periods
PeriodTypeDateEstimatesUpDownMeanLowHigh
2026Q4S2026-11-104000.000.000.00
2026Q4S2026-08-114000.000.000.00
2026Q4S2026-05-124000.000.000.00
2026Q4S2026-03-304000.000.000.00
2026Q4S2026-02-273000.000.000.00
2026Q4S2026-02-261000.000.000.00
2026Q4R2026-11-10100-0.64-0.64-0.64
2026Q4R2026-10-25100-0.64-0.64-0.64
2026Q4R2026-10-22110-0.64-0.64-0.64
2026Q4R2026-08-22210-0.55-0.64-0.45
2026Q4R2026-08-11220-0.55-0.64-0.45
2026Q4R2026-07-06211-0.60-0.74-0.45
2026Q4R2026-06-08211-0.55-0.65-0.45
2026Q4R2026-06-07101-0.65-0.65-0.65

Estimate history

EPS, annual-0.47-0.778-2.233-2.6194
Period202320242025TTM
EPS, quarterly-0.185-0.391-0.482-0.604-0.755-0.804-0.563-0.498
PeriodQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Sales, annual000
Period202320242025
Sales, quarterly00000000
PeriodQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Shares, annual35.07735.07737.3442.186
Period202320242025MRQ
Shares, quarterly35.07737.3437.3437.3437.3437.3441.7842.186
PeriodQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Income statement, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY
Total Revenue0.000.000.000.00
Cost of Goods Sold Incl. D&A0.000.000.000.00
Gross Profit0.000.000.000.00
Selling, General and Administrative Excl. Other28.7872.3526.7817.32
Research and Development16.0762.0623.2814.97
Other Operating Expense0.000.000.000.00
Operating Income-28.78-72.35-26.78-17.32
Interest Expense0.000.000.580.04
Unusual Expense0.000.000.000.00
Net Income Before Taxes-21.00-70.00-26.49-16.49
Income Taxes0.000.000.000.00
Consolidated Net Income-21.00-70.00-26.49-16.49
Net Income From Continuing Operations-21.00-70.00-26.49-16.49
Net Income-21.00-83.37-27.30-16.49
EPS (Recurring)-0.50-2.23-0.78-0.47
EPS (Basic, Before Extraordinaries)-0.50-2.23-0.78-0.47
EPS (Diluted)-0.50-2.23-0.78-0.47
EBITDA-28.78-72.35-26.78-17.32
Non-Operating Income (Expense)7.782.350.880.87
Other After Tax Adjustments0.000.000.000.00
Stock Option Compensation Expense4.091.440.250.21
Shares Outstanding42.1937.3435.0835.08
Market Capitalization6,541.096,541.09--

Income statement, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q22025Q12024Q4
Total Revenue0.000.000.000.000.000.000.000.00
Cost of Goods Sold Incl. D&A0.000.000.000.000.000.000.000.00
Gross Profit0.000.000.000.000.000.000.000.00
Selling, General and Administrative Excl. Other28.7829.5529.8623.0120.3516.0712.915.97
Research and Development16.0718.6120.9318.1918.1014.3311.454.95
Other Operating Expense0.000.000.000.000.000.000.000.00
Operating Income-28.78-29.55-29.86-23.01-20.35-16.07-12.91-5.97
Interest Expense0.000.000.000.530.000.000.000.29
Unusual Expense0.000.000.000.000.000.000.000.00
Net Income Before Taxes-21.00-23.50-27.23-21.85-20.10-15.64-12.40-5.66
Income Taxes0.000.000.000.000.000.000.000.00
Consolidated Net Income-21.00-23.50-27.23-21.85-20.10-15.64-12.40-5.66
Net Income From Continuing Operations-21.00-23.50-27.23-21.85-20.10-15.64-12.40-5.66
Net Income-21.00-23.50-30.01-28.21-22.57-18.01-14.58-6.47
EPS (Recurring)-0.50-0.56-0.80-0.76-0.60-0.48-0.39-0.18
EPS (Basic, Before Extraordinaries)-0.50-0.56-0.80-0.76-0.60-0.48-0.39-0.18
EPS (Diluted)-0.50-0.56-0.80-0.76-0.60-0.48-0.39-0.18
EBITDA-28.78---23.01-20.35---5.97
Non-Operating Income (Expense)7.786.052.631.700.240.430.520.60
Other After Tax Adjustments0.000.000.000.000.000.000.000.00
Stock Option Compensation Expense4.093.525.260.970.140.120.210.09
Shares Outstanding42.1941.7837.3437.3437.3437.3437.3435.08
Market Capitalization6,541.095,136.272,357.992,272.11----

Balance sheet, annual

Currency USD, millions
Metric2025FY2024FY2023FY
Cash & Short Term Investments141.8653.0816.30
Short Term Receivables1.251.380.00
Inventories0.000.000.00
Other Current Assets5.991.081.27
Total Current Assets149.1155.5317.56
Net Property, Plant & Equipment0.020.000.00
Total Investments and Advances0.000.000.00
Long-Term Note Receivable1.853.850.89
Intangible Assets-0.000.00
Other Assets3.490.000.00
Total Assets154.4759.3818.46
Short Term Debt Incl. Current Port. of LT Debt0.000.000.00
Accounts Payable0.002.251.85
Other Current Liabilities9.152.471.20
Total Current Liabilities9.154.723.05
Long Term Debt0.000.000.79
Provision for Risks Charges0.000.000.00
Other Liabilities0.000.000.00
Total Liabilities9.164.723.84
Non-Equity Reserves0.000.000.00
Preferred Stock - Carrying Value266.33103.1436.86
Common Equity-121.01-48.48-22.24
Total Shareholders Equity145.3154.6614.62
Accumulated Minority Interest0.000.000.00
Total Equity145.3154.6614.62
Total Liabilities & Stockholders Equity154.4759.3818.46
Book Value Per Share-3.24-1.38-0.63
Tangible Book Value Per Share-3.24-1.38-0.63
Full-Time Employees21--
Price to Book Ratio8.29--
Return on Assets-65.46-68.06-
Return on Equity-70.00-76.46-
Return on Invested Capital-48.17-48.46-107.05
Quick Ratio16.2911.775.75
Current Ratio16.2911.775.75

Cash flow, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY
Net Income-21.00-70.00-26.49-16.49
Other Funds (Non Cash)3.242.282.072.06
Funds from Operations-17.76-67.72-24.42-14.43
Extraordinary Item0.000.000.000.00
Changes in Working Capital-5.19-3.890.730.92
Cash from Operating Activities-22.95-71.60-23.69-13.51
Capital Expenditures-0.35-0.020.000.00
Net Assets From Acquisitions0.000.000.000.00
Sale of Fixed Assets and Businesses0.000.000.000.00
Purchase or Sale of Investments-165.21-118.830.000.00
Purchase of Investments-209.82-143.850.000.00
Sale Or Maturity of Investments44.6125.020.000.00
Other Uses0.000.000.000.00
Other Sources0.000.000.000.00
Cash from Investing Activities-165.56-118.860.000.00
Cash Dividends Paid0.000.000.000.00
Preferred Dividends (Cash Flow)---0.00
Change in Capital Stock1.33159.1452.8113.89
Repurchase of Common Pref Stock0.000.000.000.00
Sale of Common Pref Stock1.33159.1452.8113.89
Proceedsfrom Stock Options0.00158.9952.8113.89
Issuance or Reduction of Debt, Net0.000.007.660.00
Change in Long Term Debt0.000.007.660.00
Issuance of Long Term Debt0.000.008.510.00
Reduction of Long Term Debt0.000.00-0.840.00
Net Financing Active Other Cash Flow0.000.000.000.00
Other Financing Activities Uses0.000.000.000.00
Cash from Financing Activities1.33159.1460.4813.89
Net Change in Cash-187.18-31.3236.790.39
Free Cash Flow-23.29-71.63-23.69-13.51
Deferred Taxes & Investment Tax Credit-0.000.000.00

Balance sheet, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Cash & Short Term Investments798.35819.89390.80141.86--
Short Term Receivables1.241.591.651.25--
Inventories0.000.000.000.00--
Other Current Assets6.203.264.625.99--
Total Current Assets805.78824.75397.07149.11--
Net Property, Plant & Equipment0.390.040.020.02--
Total Investments and Advances0.000.000.000.00--
Other Assets1.040.950.273.49--
Total Assets807.22826.33398.58154.47--
Short Term Debt Incl. Current Port. of LT Debt0.000.000.000.00--
Accounts Payable0.000.000.000.00--
Other Current Liabilities10.3711.696.729.15--
Total Current Liabilities10.3711.696.729.15--
Long Term Debt0.370.430.000.00--
Provision for Risks Charges0.000.000.000.00--
Other Liabilities0.000.000.000.00--
Total Liabilities10.7412.126.729.16--
Non-Equity Reserves0.000.000.000.00--
Preferred Stock - Carrying Value0.000.000.00266.33--
Common Equity796.47814.21391.87-121.01--
Total Shareholders Equity796.47814.21391.87145.31--
Accumulated Minority Interest0.000.000.000.00--
Total Equity796.47814.21391.87145.31--
Total Liabilities & Stockholders Equity807.22826.33398.58154.47--
Book Value Per Share18.8819.4910.49-3.24--
Tangible Book Value Per Share18.8819.4910.49-3.24--
Full-Time Employees51372421--
Price to Book Ratio8.2911.71-19.49-18.78--
Return on Assets----65.46--
Return on Equity----70.00--
Return on Invested Capital-2.64-2.88-6.95-15.03--
Quick Ratio77.6870.5359.1216.29--
Current Ratio77.6870.5359.1216.29--

Cash flow, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Net Income-21.00-23.50-27.23---15.64
Other Funds (Non Cash)3.244.215.81--0.37
Funds from Operations-17.76-19.30-21.42---15.28
Extraordinary Item0.000.000.00--0.00
Changes in Working Capital-5.194.810.25---0.37
Cash from Operating Activities-22.95-14.49-21.17---15.64
Capital Expenditures-0.35-0.020.00--0.00
Net Assets From Acquisitions0.000.000.00--0.00
Sale of Fixed Assets and Businesses0.000.000.00--0.00
Purchase or Sale of Investments-165.21-277.27-101.30---8.33
Purchase of Investments-209.82-305.58-122.99---8.33
Sale Or Maturity of Investments44.6128.3121.69--0.00
Other Uses0.000.000.00--0.00
Other Sources0.000.000.00--0.00
Cash from Investing Activities-165.56-277.29-101.30---8.33
Cash Dividends Paid0.000.000.00--0.00
Change in Capital Stock1.33442.70269.11--0.13
Repurchase of Common Pref Stock0.000.000.00--0.00
Sale of Common Pref Stock1.33442.70269.11--0.13
Proceedsfrom Stock Options0.00414.33269.10--0.00
Issuance or Reduction of Debt, Net0.000.000.00--0.00
Change in Long Term Debt0.000.000.00--0.00
Issuance of Long Term Debt0.000.000.00--0.00
Reduction of Long Term Debt0.000.000.00--0.00
Net Financing Active Other Cash Flow0.000.000.00--0.00
Other Financing Activities Uses0.000.000.00--0.00
Cash from Financing Activities1.33442.70269.11--0.13
Net Change in Cash-187.18150.92146.65---23.84
Free Cash Flow-23.29-14.51-21.17---15.64

Revenue breakdown

Revenue split-

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-3011.35%3.4M29.9M789.05K
2026-10-1512.39%3.7M29.9M790.08K
2026-09-3014.21%4.2M29.9M721.21K
2026-09-1513.58%4.1M30.3M744.48K
2026-08-3113.31%4.0M30.3M718.84K
2026-08-1413.26%4.0M30.3M701.53K
2026-07-3115.47%4.8M31.2M645.20K
2026-07-1512.63%3.9M31.2M669.55K
2026-06-3012.23%3.8M31.2M661.57K
2026-06-158.00%2.5M31.2M576.91K
2026-05-297.90%2.4M29.9M554.46K
2026-05-156.86%2.1M29.9M522.49K
2026-04-306.49%2.1M31.7M533.48K
2026-04-156.23%1.8M28.8M465.02K
2026-03-318.64%2.3M26.8M457.22K
2026-03-135.20%1.4M26.8M409.16K
2026-02-274.72%1.3M26.8M496.50K
2026-02-133.85%1.0M26.8M755.66K

Option chain

expiry 2026-11-20
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
call55.0098.70103.50.004.7320.000.000.993-0.0880.005
call60.0093.6098.500.004.3740.000.000.990-0.1200.007
call65.0088.6093.500.004.0020.000.000.989-0.1190.007
call70.0083.6088.500.003.7460.000.000.988-0.1190.008
call75.0078.7083.500.003.4660.000.000.971-0.2640.016
call80.0073.7078.5027.603.2051.000.000.969-0.2610.017
call85.0068.7073.500.002.9600.000.000.966-0.2580.018
call90.0064.0068.9021.302.7280.000.000.963-0.2540.020
call95.0059.0063.900.002.5090.000.000.960-0.2500.021
call10054.0058.0048.502.2711380.000.956-0.2460.023
call10549.0053.9022.412.0999.000.000.952-0.2410.024
call11044.0048.9034.301.9069.000.000.947-0.2360.026
call11539.0043.5034.331.81138.000.000.943-0.2210.028
call12034.0038.5029.231.6031490.000.937-0.2140.030
call12529.5033.5013.171.36436.000.000.926-0.2150.034
call13024.5028.509.871.26348.000.000.916-0.2060.038
call13519.5024.0015.081.10250.000.000.902-0.1950.042
call14016.8019.5016.100.9961263.000.852-0.2410.056
call14512.4015.5012.100.93316.005.000.767-0.3130.074
call1508.6010.107.200.63592.0080.000.649-0.4340.090
call1554.008.504.450.83218.002.000.552-0.4770.096
call1601.704.402.000.6285021.000.430-0.3810.095
call1650.004.901.000.80680.000.000.365-0.4450.091
call1700.052.000.800.68830.000.000.222-0.2860.072
call1750.004.901.000.79579.000.000.197-0.3070.067
call1800.000.700.650.66869512.000.096-0.1580.041
call1850.004.900.000.7200.000.000.074-0.1390.034
call1900.004.900.001.6950.000.000.218-0.6480.069
call1950.004.900.001.7990.000.000.210-0.6710.068
call2000.004.900.001.8980.000.000.202-0.6930.066
call2100.004.900.002.0840.000.000.189-0.7310.064
put55.000.004.900.053.03131.000.00-0.007-0.0820.005
put60.000.004.900.002.8020.000.00-0.011-0.1080.007
put65.000.004.900.402.57410.000.00-0.012-0.1070.008
put70.000.004.900.102.52025.000.00-0.012-0.1110.008
put75.000.004.903.003.1411.000.00-0.051-0.4270.025
put80.000.004.900.102.59773.000.00-0.031-0.2520.017
put85.000.004.902.492.39213.000.00-0.034-0.2480.018
put90.000.004.901.602.43310.000.00-0.066-0.4030.030
put95.000.004.900.152.12423.000.00-0.060-0.3320.028
put1000.004.900.151.83820.000.00-0.044-0.2350.023
put1050.004.902.501.82422.000.00-0.087-0.3720.037
put1100.004.900.251.59426.000.00-0.062-0.2660.030
put1150.004.901.001.45426.000.00-0.107-0.3450.043
put1200.004.903.251.27750.000.00-0.121-0.3290.047
put1250.004.906.501.1199.000.00-0.086-0.2390.038
put1300.004.902.100.96721.001.00-0.097-0.2270.042
put1350.250.851.650.76341.000.00-0.098-0.1800.042
put1400.501.352.250.71624.000.00-0.148-0.2250.056
put1451.102.354.500.6820.0010.00-0.233-0.2970.074
put1501.055.5021.380.9167.000.00-0.351-0.4180.090
put1552.907.500.000.8860.000.00-0.448-0.4600.096
put1605.7010.400.000.8600.000.00-0.562-0.3750.096
put1659.0013.500.000.8830.000.00-0.640-0.4100.091
put17012.6017.300.000.9330.000.00-0.769-0.2710.074
put17517.5022.000.000.9770.000.00-0.803-0.2870.067
put18022.0026.500.001.0370.000.00-0.904-0.1380.041
put18527.0031.500.001.1530.000.00-0.914-0.1460.038
put19031.6036.400.001.2480.000.00-0.921-0.1520.036
put19536.6041.400.001.3340.000.00-0.927-0.1580.034
put20041.5046.400.001.5300.000.00-0.931-0.1630.032
put21051.5056.400.001.7170.000.00-0.939-0.1710.029

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-11-1010-QQuarterly report pursuant to Section 13 or 15(d)2026-09-30SEC
2026-11-108-KCurrent report2026-11-10SEC
2026-11-098-KCurrent report2026-11-09SEC
2026-10-198-KCurrent report2026-10-19SEC
2026-10-13SCHEDULE 13GSEC
2026-09-034Statement of changes in beneficial ownership of securities2026-09-01SEC
2026-08-21SCHEDULE 13D/ASEC
2026-08-214Statement of changes in beneficial ownership of securities2026-08-19SEC
2026-08-203Initial statement of beneficial ownership of securities2026-08-10SEC
2026-08-19144Filing for proposed sale of securities under Rule 144.SEC
2026-08-19144Filing for proposed sale of securities under Rule 144.SEC
2026-08-184Statement of changes in beneficial ownership of securities2026-08-17SEC
2026-08-184Statement of changes in beneficial ownership of securities2026-08-17SEC
2026-08-17144Filing for proposed sale of securities under Rule 144.SEC
2026-08-17144Filing for proposed sale of securities under Rule 144.SEC
2026-08-14EFFECTEffectiveness filing by commission orderSEC
2026-08-14144/ASEC
2026-08-144Statement of changes in beneficial ownership of securities2026-08-12SEC
2026-08-14424B3SEC
2026-08-14SCHEDULE 13D/ASEC
2026-08-12144Filing for proposed sale of securities under Rule 144.SEC
2026-08-12144Filing for proposed sale of securities under Rule 144.SEC
2026-08-1110-QQuarterly report pursuant to Section 13 or 15(d)2026-06-30SEC
2026-08-118-KCurrent report2026-08-11SEC
2026-08-07S-1General form of registration statement for all companies including face-amount certificate companiesSEC
2026-08-06SCHEDULE 13GSEC
2026-07-158-KCurrent report2026-07-15SEC
2026-05-15DNotice of sales of securities on Form D (Regulation D)SEC
2026-05-15SCHEDULE 13G/ASEC
2026-05-1210-QQuarterly report pursuant to Section 13 or 15(d)2026-03-31SEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-110000
2026-100000
2026-090000
2026-0800103.12M4
2026-070000
2026-060000
2026-050000
2026-040000
2026-030000
2026-0254.09M700
2026-010000
2025-120000
2025-110000

Institutional holders

Manager% owned
MONTANOVA CAPITAL, LLC9.98%
FMR LLC7.33%
SR ONE CAPITAL MANAGEMENT, LP5.75%
Deep Track Capital, LP4.79%
CITADEL ADVISORS LLC4.49%
Siren, L.L.C.3.96%
BlackRock, Inc.3.81%
VIKING GLOBAL INVESTORS LP3.74%
JPMORGAN CHASE & CO2.79%
D. E. Shaw & Co., Inc.2.43%

Funds

Fund% owned
Fidelity Growth Company Fund1.85%
VANGUARD TOTAL STOCK MARKET INDEX FUND1.48%
iShares Russell 2000 ETF1.28%
abrdn Healthcare Investors0.90%
JPMorgan Growth Advantage Fund0.77%
abrdn Healthcare Opportunities Fund0.65%
JPMorgan Small Cap Growth Fund0.63%
Fidelity Small Cap Index Fund0.57%
VANGUARD EXTENDED MARKET INDEX FUND0.55%
Fidelity Growth Company K6 Fund0.52%

OakChart. MANE. Cached 15 minutes.